Medication safety in neonates

Rabih Dabliz1, Stuart Levine

  • 1Institute for Safe Medication Practices, Horsham, Pennsylvania 19044, USA. rdabliz@hotmail.com

Insights

Newborn intensive care units (NICUs) are high-risk environments where medication errors can harm vulnerable infants. Implementing safe medication practices requires collaboration among all healthcare professionals to protect neonates.

Area of Science:

  • Neonatal care
  • Patient safety
  • Medication management

Background:

  • Newborn intensive care units (NICUs) are critical care settings for vulnerable infants.
  • The NICU environment poses risks for medication errors, potentially causing severe harm or death.
  • Safe medication practices are essential for improving outcomes in neonates.

Purpose of the Study:

  • To highlight significant areas of concern regarding medication use in NICUs.
  • To emphasize the need for a collaborative approach to medication safety.
  • To provide recommendations for a safe and efficient medication use system in NICUs.

Main Methods:

  • Recommendations organized according to the Institute for Safe Medication Practices' Key Elements of the Medication Use System™.
  • Focus on significant areas of concern within the NICU medication use process.
  • Involves participation of all individuals in the medication use process.

Main Results:

  • Identified NICUs as high-risk areas for medication errors.
  • Stressed the critical role of all healthcare professionals in medication safety.
  • Highlighted the importance of administrative and organizational leadership support.

Conclusions:

  • All individuals involved in neonatal care are responsible partners in ensuring medication safety.
  • A safe and efficient medication use system requires active participation in its design and sustainment.
  • Promoting safe medication practices is crucial for the well-being of neonates in the NICU.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...